Anyone researching retatrutide dosing or tracking the availability of retatrutide should factor hair loss risk into their consideration
Dosing & Titration Understanding dosing and titration is essential for maximizing the effectiveness of GLP-1 medications
In addition, preoperative digestive symptoms (nausea, vomiting, dyspepsia, abdominal distension) and semaglutide use within the 30 days prior to EGD were shown to increase the risk of increased RGC by 5.15 and 3.56 times, respectively
This is followed by the release of nesfatin-1 which stimulates cholecystokinin secretion leading to a rise in bile salts from gallbladder emptying, and the binding of Takeda P protein coupled receptor 5 (TGR5) onto the surface of the enteroendocrine cells, all of which eventually culminates in GLP-1 secretion [9]
The beneficial effects of single molecule GLP-1/Gcg coagonism were also demonstrated in ob/ob mice, which had enhanced GSIS and improved glucose tolerance upon acute treatment with a GLP-1/Gcg coagonist (Gault et al., 2013)